<DOC>
	<DOC>NCT00243165</DOC>
	<brief_summary>This study will include 60 patients with early breast cancer referred to receive adjuvant chemotherapy with AC ( adriamycin- cyclophosphamide) or CAF ( adriamycin- cyclophosphamide- 5- fluorouracil ) combinations. These patients will receive every day one spoon of Lifemel honey or regular honey ( double blind)- during the adjuvant chemotherapy .Every week a WBC count will be performed in order to record the influence of Lifemel on myelotoxicity.</brief_summary>
	<brief_title>Lifemel Honey to Reduce Leucopenia During Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Leukopenia</mesh_term>
	<criteria>breast cancer patient treated with adjuvant chemotherapy PS = 2 or less</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>honey</keyword>
	<keyword>myelosuppression</keyword>
	<keyword>chemotherapy</keyword>
</DOC>